"The Importance of Adding Fenestration to Ultrasound-Guided Baker's Cyst Aspiration"
1 other identifier
interventional
44
1 country
1
Brief Summary
This study aims to evaluate whether adding a fenestration procedure to standard ultrasound-guided aspiration and corticosteroid-lidocaine injection provides additional clinical benefits for patients with symptomatic Baker's cyst associated with knee osteoarthritis. Baker's cyst is a fluid-filled swelling located behind the knee that may cause pain, stiffness, swelling, and limited mobility. Although aspiration with medication injection is commonly used to relieve symptoms, recurrence of the cyst is frequent. Fenestration is a minimally invasive technique in which small controlled openings are created in the cyst wall under ultrasound guidance to improve internal drainage and potentially reduce recurrence. In this prospective, randomized, double-blind, controlled study, participants will be assigned to one of two groups:
- 1.aspiration with corticosteroid and lidocaine injection, or
- 2.aspiration with corticosteroid and lidocaine injection plus fenestration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2026
CompletedFirst Posted
Study publicly available on registry
February 4, 2026
CompletedStudy Start
First participant enrolled
February 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 30, 2026
February 4, 2026
January 1, 2026
3 months
January 22, 2026
January 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Baker's Cyst Volume
Baker's cyst volume measured by ultrasonography using three-dimensional linear measurements (height × width × depth) and calculated in cubic millimeters (mm³). Volume measurements will be compared between the two study groups (Aspiration + Steroid-Lidocaine vs. Aspiration + Steroid-Lidocaine + Fenestration). All measurements will be performed by a blinded physician using a 7-13 MHz linear transducer. Lower values indicate a reduction in cyst size.
Baseline, 2 weeks, 1 month, and 3 months after the intervention
Secondary Outcomes (9)
Change in Pain Severity (NRS Score)
Baseline, 1 hour post-procedure, 2 weeks, 1 month, 3 months.
Change in Rauschning-Lindgren Classification (RLC)
Baseline, 2 weeks, 1 month, 3 months.
Change in Knee Injury and Osteoarthritis Outcome Score (KOOS)
Baseline, 2 weeks, 1 month, 3 months.
Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Baseline, 2 weeks, 1 month, 3 months.
Baseline OMERACT Ultrasound Score
Baseline
- +4 more secondary outcomes
Other Outcomes (1)
Post-Procedure Pain Change (Short-Term Response)
Baseline and 1 hour after the procedure.
Study Arms (2)
Aspiration + Steroid-Lidocaine
ACTIVE COMPARATORUltrasound-guided aspiration of Baker's cyst followed by injection of corticosteroid and lidocaine mixture. No fenestration is performed.
Arm Title: Aspiration + Steroid-Lidocaine + Fenestration
EXPERIMENTALUltrasound-guided aspiration followed by corticosteroid-lidocaine injection and fenestration using multiple needle perforations under real-time ultrasound guidance.
Interventions
With the patient in the prone position, the ultrasound probe is placed transversely over the gastrocnemius-semimembranosus bursa. Under real-time ultrasound guidance, the needle is advanced while visualizing neurovascular structures to avoid injury. Aspiration of the cyst content is performed in all participants.
Following aspiration, an injection mixture consisting of 1 mL betamethasone, 1 mL of 2% lidocaine, and 1 mL of 0.9% isotonic sodium chloride is administered into the decompressed cyst cavity under ultrasound guidance.
After aspiration, fenestration of the cyst wall is performed under ultrasound guidance. The cyst wall is punctured at a minimum of six different points using a needle to create communication with surrounding tissues and reduce recurrence. Following fenestration, the same steroid and local anesthetic mixture is administered.
Eligibility Criteria
You may qualify if:
- Adults aged 40 to 75 years
- Diagnosis of knee osteoarthritis according to the 2010 American College of Rheumatology (ACR) criteria
- Presence of a symptomatic Baker's cyst confirmed by ultrasonography
- Ability to understand study procedures and provide written informed consent
- Sufficient intellectual and social capacity to comply with study visits and follow-up requirements
You may not qualify if:
- Presence of inflammatory arthritis, septic arthritis, crystal arthropathy, or secondary causes of knee osteoarthritis
- Kellgren-Lawrence grade 4 knee osteoarthritis
- Active systemic infection
- History of malignancy
- Intra-articular knee injection within the past 3 months
- Knee trauma within the past 3 months
- History of knee surgery
- Contraindications to aspiration or corticosteroid injection (e.g., local infection, bleeding disorders, uncontrolled diabetes mellitus)
- Requirement to continue medications for inflammatory arthritis
- Diagnosed psychiatric disorder that may impair study participation
- Use of nonsteroidal anti-inflammatory drugs (NSAIDs) within the past 1 week
- Physical therapy applied to the knee region within the past 1 month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Department of Physical Medicine and Rehabilitation
Istanbul, Istanbul, 34098, Turkey (Türkiye)
Related Publications (10)
Kim JM, Kang S, Yoon JS. Association of complicated Baker's cysts with knee pathologies as compared to simple Baker's cysts. Medicine (Baltimore). 2024 Jun 7;103(23):e38407. doi: 10.1097/MD.0000000000038407.
PMID: 38847688BACKGROUNDMortada M, Amer YA, Zaghlol RS. Efficacy and Safety of Musculoskeletal Ultrasound Guided Aspiration and Intra-Lesional Corticosteroids Injection of Ruptured Baker's Cyst: A Retrospective Observational Study. Clin Med Insights Arthritis Musculoskelet Disord. 2020 Nov 10;13:1179544120967383. doi: 10.1177/1179544120967383. eCollection 2020.
PMID: 33223862BACKGROUNDCollins NJ, Misra D, Felson DT, Crossley KM, Roos EM. Measures of knee function: International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, Knee Injury and Osteoarthritis Outcome Score (KOOS), Knee Injury and Osteoarthritis Outcome Score Physical Function Short Form (KOOS-PS), Knee Outcome Survey Activities of Daily Living Scale (KOS-ADL), Lysholm Knee Scoring Scale, Oxford Knee Score (OKS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Activity Rating Scale (ARS), and Tegner Activity Score (TAS). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11(0 11):S208-28. doi: 10.1002/acr.20632. No abstract available.
PMID: 22588746BACKGROUNDFerdousi A, Islam MA, Begum M, Debnath MR, Shapla SP, Saha T, Biswas R, Ferdouse F, Rahman MA. Diagnostic Value of Ultrasonography in Determination of Knee Joint Pathologies with Comparison to MRI. Mymensingh Med J. 2024 Oct;33(4):989-995.
PMID: 39351715BACKGROUNDBandinelli F, Fedi R, Generini S, Porta F, Candelieri A, Mannoni A, Innocenti M, Matucci Cerinic M. Longitudinal ultrasound and clinical follow-up of Baker's cysts injection with steroids in knee osteoarthritis. Clin Rheumatol. 2012 Apr;31(4):727-31. doi: 10.1007/s10067-011-1909-9. Epub 2011 Dec 27.
PMID: 22200813BACKGROUNDChen CK, Lew HL, Liao RI. Ultrasound-guided diagnosis and aspiration of Baker's cyst. Am J Phys Med Rehabil. 2012 Nov;91(11):1002-4. doi: 10.1097/PHM.0b013e318269d95b. No abstract available.
PMID: 22955026BACKGROUNDOo WM, Linklater JM, Bennell KL, Pryke D, Yu S, Fu K, Wang X, Duong V, Hunter DJ. Are OMERACT Knee Osteoarthritis Ultrasound Scores Associated With Pain Severity, Other Symptoms, and Radiographic and Magnetic Resonance Imaging Findings? J Rheumatol. 2021 Feb;48(2):270-278. doi: 10.3899/jrheum.191291. Epub 2020 May 15.
PMID: 32414954BACKGROUNDAcebes JC, Sanchez-Pernaute O, Diaz-Oca A, Herrero-Beaumont G. Ultrasonographic assessment of Baker's cysts after intra-articular corticosteroid injection in knee osteoarthritis. J Clin Ultrasound. 2006 Mar-Apr;34(3):113-7. doi: 10.1002/jcu.20210.
PMID: 16547992BACKGROUNDSmith MK, Lesniak B, Baraga MG, Kaplan L, Jose J. Treatment of Popliteal (Baker) Cysts With Ultrasound-Guided Aspiration, Fenestration, and Injection: Long-term Follow-up. Sports Health. 2015 Sep-Oct;7(5):409-14. doi: 10.1177/1941738115585520. Epub 2015 May 5.
PMID: 26502415BACKGROUNDAbate M, Di Carlo L, Di Iorio A, Salini V. Baker's Cyst with Knee Osteoarthritis: Clinical and Therapeutic Implications. Med Princ Pract. 2021;30(6):585-591. doi: 10.1159/000518792. Epub 2021 Aug 2.
PMID: 34348320BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
TUTKU NAZ BULUT, MD
Istanbul University - Cerrahpasa
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- This is a double-blind study. Participants and investigators who perform evaluations are blinded to group assignment. The clinician performing the ultrasound-guided procedure is not involved in outcome assessments.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident Physician, Department of Physical Medicine and Rehabilitation
Study Record Dates
First Submitted
January 22, 2026
First Posted
February 4, 2026
Study Start
February 15, 2026
Primary Completion (Estimated)
May 30, 2026
Study Completion (Estimated)
May 30, 2026
Last Updated
February 4, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Individual participant-level data will not be shared. Study results will be reported in aggregated form in a manner that does not allow identification of individual participants.